4 months ago
GMED
AnalystsVik ChopraVik Chopra's Stock Forecasts
AnalystsVik Chopra
Analyst Ranking
Top 29%
#1527 out of 5298 analysts
Average Return
+4.74%
Win Rate
50%15 out of 30
Risk vs Reward
Poor
Good
Vik Chopra's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuropace IncNPCE | +61.16% | $9.32 | $15.02 | 2025-08-12 - 2026-06-16 | Strong Buy |
Alphatec Holdings IncATEC | +59.34% | $6.64 | $10.58 | 2024-07-31 - 2025-07-31 | Strong Buy |
Neuropace IncNPCE | +47.54% | $9.15 | $13.50 | 2024-11-12 - 2025-11-12 | Strong Buy |
Align Technology IncALGN | +39.15% | $129.01 | $179.52 | 2025-07-30 - 2026-06-16 | Strong Buy |
Neuropace IncNPCE | +37.67% | $6.77 | $9.32 | 2024-08-13 - 2025-08-13 | Strong Buy |
Vik Chopra Analyst Color
Get additional color on Vik Chopra's coverage of popular stocks
a year ago
MASI
Vik Chopra's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Solventum CorpSOLV | 6 | Hold | $83.00 | +8.41% | Maintains | 4 months ago |
Integra Lifesciences Holdings CorpIART | 3 | Hold | $12.00 | -32.24% | Maintains | 4 months ago |
Dentsply Sirona IncXRAY | 5 | Hold | $13.00 | +24.40% | Maintains | 4 months ago |
Globus Medical IncGMED | 12 | Strong Buy | $104.00 | +34.16% | Maintains | 4 months ago |
Henry Schein IncHSIC | 4 | Hold | $87.00 | +7.13% | Maintains | 4 months ago |
Masimo CorpMASI | 11 | Hold | $180.00 | +0.03% | Downgrades | 4 months ago |
Envista Holdings CorpNVST | 4 | Hold | $26.00 | +5.05% | Maintains | 4 months ago |
Align Technology IncALGN | 5 | Strong Buy | $200.00 | +11.41% | Maintains | 4 months ago |
Conmed CorpCNMD | 7 | Hold | $42.00 | +21.49% | Maintains | 5 months ago |
Enovis CorpENOV | 5 | Strong Buy | $42.00 | +94.62% | Maintains | 7 months ago |
Neuropace IncNPCE | 4 | Strong Buy | $16.00 | +6.52% | Maintains | 7 months ago |
Alphatec Holdings IncATEC | 2 | Strong Buy | $16.00 | +89.57% | Maintains | 8 months ago |
Nuvasive IncNUVA | 2 | Hold | $57.72 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.